SIBN

SI-BONE, Inc.

SIBN | $15.44 0.92% 0.91% 590K

(0.0% 1d) (-5.0% 1m) (-31.5% 1y) (0.0% 2d) (0.0% 3d) (-0.3% 7d) (-35.4% volume)
Earnings Calendar: 2024-02-26
Market Cap: $ 634,043,600
http://www.si-bone.com
Sec Filling | Patents | 262 employees

(US) SI-BONE, Inc. is a medical device company. It focuses on the development of implantable devices used in the surgical treatment of the sacropelvic anatomy. The firm’s product, iFuse, seeks to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded by Mark A. Reiley and Jeffrey W. Dunn on March 18, 2008 and is headquartered in San Jose, CA.

bone treatment

add to watch list Paper trade email alert is off

Press-releases

SI-BONE To Report First Quarter 2024 Financial Results on May 6, 2024
Published: 2024-04-15 (Crawled : 20:00) - globenewswire.com
SIBN | $15.44 0.92% 0.91% 590K

Health Technology

| -0.26% | O: -0.52% H: 2.96% C: 0.99%
first report financial results

SI-BONE to Present at Barclays 26th Annual Global Healthcare Conference on March 12, 2024
Published: 2024-03-04 (Crawled : 21:00) - globenewswire.com
SIBN | $15.44 0.92% 0.91% 590K

Health Technology

| -14.34% | O: -0.79% H: 1.81% C: -1.3%
conference global

SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance
Published: 2024-02-26 (Crawled : 21:00) - globenewswire.com
SIBN | $15.44 0.92% 0.91% 590K

Health Technology

| -25.85% | O: -9.64% H: 3.39% C: -4.31%
year financial results

SI-BONE To Report Fourth-Quarter and Full-Year 2023 Financial Results on February 26, 2024
Published: 2024-02-05 (Crawled : 21:00) - globenewswire.com
SIBN | $15.44 0.92% 0.91% 590K

Health Technology

| -25.56% | O: -0.29% H: 2.06% C: 1.57%
report financial results

SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and Application
Published: 2024-01-30 (Crawled : 13:30) - globenewswire.com
SIBN | $15.44 0.92% 0.91% 590K

Health Technology

| -25.92% | O: 0.92% H: 0.0% C: -2.22%
fda granite clearance implant application

SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2023
Published: 2024-01-08 (Crawled : 13:30) - globenewswire.com
SIBN | $15.44 0.92% 0.91% 590K

Health Technology

| -26.85% | O: -1.54% H: 0.68% C: -5.61%
year revenue

SI-BONE To Present at Piper Sandler 35th Annual Healthcare Conference on November 28, 2023
Published: 2023-11-14 (Crawled : 21:00) - globenewswire.com
SIBN | $15.44 0.92% 0.91% 590K

Health Technology

| -12.72% | O: -0.23% H: 3.96% C: 1.26%
conference

SI-BONE, Inc. Reports Record Financial Results for the Third Quarter 2023 and Raises Annual Guidance
Published: 2023-11-06 (Crawled : 21:00) - globenewswire.com
SIBN | $15.44 0.92% 0.91% 590K

Health Technology

| -12.87% | O: 2.97% H: 1.56% C: -4.89%
financial results

SI-BONE To Present at Jefferies London Healthcare Conference on November 15, 2023
Published: 2023-11-01 (Crawled : 20:00) - globenewswire.com
SIBN | $15.44 0.92% 0.91% 590K

Health Technology

| -11.76% | O: 1.04% H: 2.35% C: 0.34%
conference

SI-BONE to Report Third Quarter 2023 Financial Results on November 6, 2023
Published: 2023-10-16 (Crawled : 20:00) - globenewswire.com
SIBN | $15.44 0.92% 0.91% 590K

Health Technology

| -11.76% | O: 0.29% H: 5.66% C: 2.66%
report financial results

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001562180-24-003312	4	2024-04-04	2024-04-03	Sell	S	920	251533
0001562180-24-003312	4	2024-04-04	2024-04-02	Sell	S	1752	252453
0001562180-24-003312	4	2024-04-04	2024-04-02	Sell	S	1555	254205
0001562180-24-003311	4	2024-04-04	2024-04-02	Sell	S	1285	205516
0001562180-24-003311	4	2024-04-04	2024-04-02	Sell	S	1140	206801
0001562180-24-002691	4	2024-03-14	2024-03-13	Sell	S	3330	255760
0001562180-24-002690	4	2024-03-14	2024-03-13	Sell	S	2500	19350